Should the Life Sciences Industry Reverse Course and Restrict the Use of DTC Advertising for its Products?
Apr 7, 2009
by Kathryn Martin
Information to patients in accordance with fair balance regulations allows patients to be a part of the decision-making process. It is a natural part of the right-to-know process. America is built on a foundation of “rights”. The right to choose (doctor, HMO, insurance, medication), the right to know (side effects, available clinical trials, treatment options) and the right to decide (which course of treatment to take).
A decade ago, former Surgeon General C. Everett Koop sent a clear message to consumers.“Become empowered about your healthcare and take responsibility.” That is what advertising in general achieves. DTC (a highly regulated advertising approach) plays an important role in increasing patient/consumer awareness, fostering dialogue with healthcare providers and empowering patients in the process.
What are your thoughts?
